LAVA Therapeutics (NASDAQ: LVTX) Gammabody™ Platform Gains Momentum

LAVA Therapeutics N.V. (NASDAQ: LVTX) shares soared 106% as the company announced that Janssen Biotech, Inc. chose a lead candidate.

Related Keywords

Jake Weber Biostockanalyst ,Brian Jones Masterbjones ,Janssen Biotech Inc ,Janssen Pharmaceutical Companies Of Johnson ,Janssen Biotech ,Janssen Pharmaceutical Companies ,Inside Scoop ,Right Now ,Johnson Innovation ,Trader Brian Jones ,Jake Weber ,Featured ,Lvtx ,